HealthCare Global Enterprises (NSE:HCG) Interest Expense: ₹-1,766 Mil (TTM As of Mar. 2026)


NSE:HCG HealthCare Global Enterprises Ltd NSE:HCG
85 GF Score
Price ₹666.40
GF Value ₹579.47
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HealthCare Global Enterprises Interest Expense?

HealthCare Global Enterprises NSE:HCG +2.10% 85 Interest Expense is ₹-1,766 Mil as of Mar. 2026. GuruFocus rates NSE:HCG with a GF Score™ of 85/100 and a GF Value™ of ₹579.47 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. HealthCare Global Enterprises's interest expense for the three months ended in Mar. 2026 was ₹ -427 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-1,766 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. HealthCare Global Enterprises's Operating Income for the three months ended in Mar. 2026 was ₹ 623 Mil. HealthCare Global Enterprises's Interest Expense for the three months ended in Mar. 2026 was ₹ -427 Mil. HealthCare Global Enterprises's Interest Coverage for the quarter that ended in Mar. 2026 was 1.46. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HealthCare Global Enterprises  (NSE:HCG) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HealthCare Global Enterprises's Interest Expense for the three months ended in Mar. 2026 was ₹-427 Mil. Its Operating Income for the three months ended in Mar. 2026 was ₹623 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ₹13,592 Mil.

HealthCare Global Enterprises's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*622.7/-427
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

HealthCare Global Enterprises Interest Expense Historical Data

* Premium members only.

The historical data trend for HealthCare Global Enterprises's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthCare Global Enterprises Interest Expense Chart

HealthCare Global Enterprises Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -867.70 -943.95 -1,006.94 -1,545.60 -1,765.70

HealthCare Global Enterprises Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -441.70 -454.70 -436.20 -447.80 -427.00
NSE:HCG
85GF Score
HealthCare Global Enterprises Ltd NSE:HCG
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthCare Global Enterprises Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1,766 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-1,766 Mil mean?
HealthCare Global Enterprises (NSE:HCG) has a Interest Expense of ₹-1,766 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on HealthCare Global Enterprises and its competitors.
Is HealthCare Global Enterprises' Interest Expense too high?
HealthCare Global Enterprises' current Interest Expense is ₹-1,766 Mil. Overall, HealthCare Global Enterprises has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Interest Expense compare to HCA and THC?
HealthCare Global Enterprises' Interest Expense of ₹-1,766 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on HealthCare Global Enterprises and its competitors. HealthCare Global Enterprises's current Interest Expense is ₹-1,766 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹579.47, compared to a current price of ₹666.40 — trading 15% above its estimated fair value. The current Interest Expense is ₹-1,766 Mil. HealthCare Global Enterprises' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Interest Expense is ₹-1,766 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?

Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued. The current stock price of ₹666.40 is trading 15% above its estimated GF Value™ of ₹579.47. GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.

Key valuation signals for NSE:HCG:

  • Interest Expense: ₹-1,766 Mil
  • GF Value™: ₹579.47 vs. price of ₹666.40 (15% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthCare Global Enterprises Business Description

Other Exchanges 539787:India
Address Mission Road, No. 3, Ground Floor, Tower Block, Unity Building Complex, Bengaluru, KA, IND, 560027
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
85GF Score

Get the complete analysis for NSE:HCG

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹666.40
Price
₹579.47
GF Value